PATHWAY: ko05120 Help
Entry
Name
Epithelial cell signaling in Helicobacter pylori infection
Description
Two major virulence factors of H. pylori are the vacuolating cytotoxin (VacA) and the cag type-IV secretion system (T4SS) and its translocated effector protein, cytotoxin-associated antigen A (CagA).
VacA binds to lipid rafts and glycosylphosphatidylinositol-anchored proteins (GPI-APs) of the target cell membrane. After insertion into the plasma membrane, VacA channels are endocytosed and eventually reach late endosomal compartments, increasing their permeability to anions with enhancement of the electrogenic vacuolar ATPase (v-ATPase) proton pump. In the presence of weak bases, osmotically active acidotropic ions will accumulate in the endosomes. This leads to water influx and vesicle swelling, an essential step in vacuole formation. In addition, it is reported that the VacA cleavage product binds to the tyrosine phosphatase receptor zeta (Ptprz) on epithelial cells and the induced signaling leads to the phosphorylation of the G protein-coupled receptor kinase-interactor 1 (Git1) and induces ulcerogenesis in mice.
The other virulence factor cag T4SS mediates the translocation of the effector protein CagA, which is subsequently phosphorylated by a Src kinase. Phosphorylated CagA interacts with the protein tyrosine phosphatase SHP-2, thus stimulating its phosphatase activity. Activated SHP-2 is able to induce MAPK signalling through Ras/Raf-dependent and -independent mechanisms. Deregulation of this pathway by CagA may lead to abnormal proliferation and movement of gastric epithelial cells.
Class
Human Diseases; Infectious disease: bacterial
BRITE hierarchy
Pathway map
ko05120 Epithelial cell signaling in Helicobacter pylori infection
Module
M00564 Helicobacter pylori pathogenicity signature, cagA pathogenicity island [PATH:ko05120 ]
Disease
H00320 Helicobacter pylori infection
Orthology
K01116 PLCG1; phosphatidylinositol phospholipase C, gamma-1 [EC:3.1.4.11 ]
K02144 ATPeV1H; V-type H+-transporting ATPase subunit H
K02145 ATPeV1A, ATP6A; V-type H+-transporting ATPase subunit A [EC:7.1.2.2 ]
K02146 ATPeV0D, ATP6D; V-type H+-transporting ATPase subunit d
K02147 ATPeV1B, ATP6B; V-type H+-transporting ATPase subunit B
K02148 ATPeV1C, ATP6C; V-type H+-transporting ATPase subunit C
K02149 ATPeV1D, ATP6M; V-type H+-transporting ATPase subunit D
K02150 ATPeV1E, ATP6E; V-type H+-transporting ATPase subunit E
K02151 ATPeV1F, ATP6S14; V-type H+-transporting ATPase subunit F
K02152 ATPeV1G, ATP6G; V-type H+-transporting ATPase subunit G
K02153 ATPeV0E, ATP6H; V-type H+-transporting ATPase subunit e
K02154 ATPeV0A, ATP6N; V-type H+-transporting ATPase subunit a
K02155 ATPeV0C, ATP6L; V-type H+-transporting ATPase 16kDa proteolipid subunit
K02580 NFKB1; nuclear factor NF-kappa-B p105 subunit
K03191 ureI; acid-activated urea channel
K03196 virB11, lvhB11; type IV secretion system protein VirB11 [EC:7.4.2.8 ]
K03661 ATPeV0B, ATP6F; V-type H+-transporting ATPase 21kDa proteolipid subunit
K03662 ATPeVS1, ATP6S1; V-type H+-transporting ATPase S1 subunit
K04175 CXCR1, IL8RA, CD181; C-X-C chemokine receptor type 1
K04392 RAC1; Ras-related C3 botulinum toxin substrate 1
K04393 CDC42; cell division control protein 42
K04430 MAP2K4, MKK4; mitogen-activated protein kinase kinase 4 [EC:2.7.12.2 ]
K04440 JNK; mitogen-activated protein kinase 8/9/10 (c-Jun N-terminal kinase) [EC:2.7.11.24 ]
K04448 JUN; transcription factor AP-1
K04466 MAP3K14, NIK; mitogen-activated protein kinase kinase kinase 14 [EC:2.7.11.25 ]
K04467 IKBKA, IKKA, CHUK; inhibitor of nuclear factor kappa-B kinase subunit alpha [EC:2.7.11.10 ]
K04734 NFKBIA; NF-kappa-B inhibitor alpha
K04735 RELA; transcription factor p65
K05050 CXCR2, IL8RB, CD182; C-X-C chemokine receptor type 2
K05099 MET, HGFR; proto-oncogene tyrosine-protein kinase Met [EC:2.7.10.1 ]
K05505 CXCL1_2_3, GRO; C-X-C motif chemokine 1/2/3
K05701 TJP1, ZO1; tight junction protein 1
K05737 GIT1; G protein-coupled receptor kinase interactor 1
K05859 PLCG2; phosphatidylinositol phospholipase C, gamma-2 [EC:3.1.4.11 ]
K06059 ADAM17, TACE, CD156b; disintegrin and metalloproteinase domain-containing protein 17 [EC:3.4.24.86 ]
K06089 F11R, JAM1, CD321; junctional adhesion molecule 1
K06704 ADAM10, CD156c; disintegrin and metalloproteinase domain-containing protein 10 [EC:3.4.24.81 ]
K06735 JAM2, CD322; junctional adhesion molecule 2
K06785 JAM3; junctional adhesion molecule 3
K06786 JAM4, JCAM; junctional adhesion molecule 4
K07209 IKBKB, IKKB; inhibitor of nuclear factor kappa-B kinase subunit beta [EC:2.7.11.10 ]
K07210 IKBKG, IKKG, NEMO; inhibitor of nuclear factor kappa-B kinase subunit gamma
K07293 PTPN11, SHP2; tyrosine-protein phosphatase non-receptor type 11 [EC:3.1.3.48 ]
K08114 PTPRZ; receptor-type tyrosine-protein phosphatase zeta [EC:3.1.3.48 ]
K08303 prtC, trhP; U32 family peptidase [EC:3.4.-.-]
K08523 HBEGF; heparin-binding EGF-like growth factor
K08727 NOD1, CARD4; nucleotide-binding oligomerization domain-containing protein 1
K10030 IL8, CXCL8; interleukin 8
K11028 vacA; vacuolating cytotoxin
K12086 cag1; cag pathogenicity island protein 1
K12087 cag2; cag pathogenicity island protein 2
K12088 cag3; cag pathogenicity island protein 3
K12089 cag4; cag pathogenicity island protein 4
K12090 cag5; cag pathogenicity island protein 5
K12091 cag6; cag pathogenicity island protein 6
K12092 cag7; cag pathogenicity island protein 7
K12093 cag8; cag pathogenicity island protein 8
K12094 cag9; cag pathogenicity island protein 9
K12095 cag10; cag pathogenicity island protein 10
K12096 cag11; cag pathogenicity island protein 11
K12097 cag12; cag pathogenicity island protein 12
K12098 cag13; cag pathogenicity island protein 13
K12099 cag14; cag pathogenicity island protein 14
K12100 cag15; cag pathogenicity island protein 15
K12101 cag16; cag pathogenicity island protein 16
K12102 cag17; cag pathogenicity island protein 17
K12103 cag18; cag pathogenicity island protein 18
K12104 cag19; cag pathogenicity island protein 19
K12105 cag20; cag pathogenicity island protein 20
K12106 cag21; cag pathogenicity island protein 21
K12107 cag22; cag pathogenicity island protein 22
K12109 cag24; cag pathogenicity island protein 24
K12110 cag25; cag pathogenicity island protein 25
K12499 CCL5; C-C motif chemokine 5
K15842 cagA; cytotoxicity-associated immunodominant antigen
K15843 hopC, alpA; outer membrane protein HopC/AlpA
K15844 hopB, alpB; outer membrane protein HopB/AlpB
K15845 hopZ; outer membrane protein HopZ
K15846 hpaA; neuraminyllactose-binding hemagglutinin
K15847 babA; outer membrane protein BabA
K15848 sabA; outer membrane protein SabA
Compound
Reference
Authors
Naumann M, Crabtree JE.
Title
Helicobacter pylori-induced epithelial cell signalling in gastric carcinogenesis.
Journal
Reference
Authors
Rieder G, Fischer W, Haas R.
Title
Interaction of Helicobacter pylori with host cells: function of secreted and translocated molecules.
Journal
Reference
Authors
Montecucco C, Rappuoli R.
Title
Living dangerously: how Helicobacter pylori survives in the human stomach.
Journal
Reference
Authors
Gerhard M, Rad R, Prinz C, Naumann M.
Title
Pathogenesis of Helicobacter pylori infection.
Journal
Related pathway